Online customer service
Customer service hotline
Customer service team:
在线客服
Skype
Wangwang:
QQ:
Service time:
8:00 - 17:00

National Advisory Hotline

400-8536-777

Add: No. 17, Tianjin North Road, Yantai Development Zone

Copyright © 2020 Yantai Huaxin Biomedical Science and Technology Co., Ltd

Lu ICP No.14008762 Powered by 300.cn

Huaxin Biomedical

WeChat

Huaxin Biomedical

Mobile official website

Yantai Huaxin Biomedical Science and Technology Co., Ltd

>
>
>
Our company was approved by Yantai City's 2019 Key R&D Plan Project

Our company was approved by Yantai City's 2019 Key R&D Plan Project

Page view
[Abstract]:
Recently, the Yantai Municipal Science and Technology Bureau announced the proposed project of the Yantai Key Research and Development Plan in 2019. The project "Research on the Effective Material Basis and Mechanism of the Classic Chinese Medicine Gentiana against Rheumatoid Arthritis" jointly declared by Yantai University and our company was approved. As a key research and development plan, the project number is "2019XDHZ109". The project is led by Yantai University.

Recently, the Yantai Municipal Science and Technology Bureau announced the proposed project of the Yantai Key Research and Development Plan in 2019. The project "Research on the Effective Material Basis and Mechanism of the Classic Chinese Medicine Gentiana against Rheumatoid Arthritis" jointly declared by Yantai University and our company was approved. As a key research and development plan, the project number is "2019XDHZ109". The project is led by Yantai University. Our company is a cooperative unit to cooperate with the development of related research work. Dr. Hou Jian participates in the research and development of the project as the company's project leader.

On November 16, 2017, our company signed a practical teaching base agreement with the School of Pharmacy of Yantai University. Since the signing of the agreement, our company and the School of Pharmacy of Yantai University have been closer to combine teaching and production. Our school and enterprise support each other , Mutual penetration, two-way intervention, complementary advantages, mutual use of resources, and benefit sharing have realized the rational integration of college education and modern enterprise management.

Rheumatoid arthritis (RA) is a chronic, inflammatory synovitis-based systemic disease of unknown etiology. It is characterized by multiple joints, symmetry, and aggressive joint inflammation of the small joints of the hands and feet. Accompanied by involvement of extra-articular organs and positive serum rheumatoid factor, it can lead to joint deformities and loss of function. It belongs to the category of "Bizheng" in traditional Chinese medicine and is one of the clinically refractory diseases. The onset of RA may be related to heredity, infection, sex hormones and so on. In recent years, a large number of experimental researches have been carried out on the anti-RA effects of natural drugs at home and abroad, mainly in antibacterial, anti-inflammatory, analgesic and immune regulation.

The successful establishment of this project reflects the government's emphasis on medical care and health in recent years. For a long time, our company has focused on serving the country's major strategic needs, strengthened the research and development of key common technologies in the health industry, and promoted the integration of production, education and research and the transformation of scientific and technological achievements. And through school-enterprise cooperation, collaborative innovation brings together new momentum for scientific research, seamlessly connecting the innovation chain and the industrial chain, forming a benign interactive development of talents, scientific research, and industrialization, providing strong support for the development of the national economy. The establishment of Yantai’s key R&D project has greatly boosted our company’s confidence in continuing to carry out high-level scientific research, and will play a positive role in further enhancing our company’s scientific and technological competitiveness, promoting the transformation of scientific and technological achievements, and serving the revitalization of the society.

Classification summary:
企业新闻
Huaxin Bio-Zhonglianhe International & Yanxuan Aishanmei project kick-off meeting was successfully held
2021-03-05
On the morning of March 4, 2021, the launch meeting of Huaxin Bio·Zhonglianhe International & Yanxuan Aishanmei Project was successfully held in Yantai Huaxin Biomedical Technology Co., Ltd.; the project kick-off meeting was Huaxin Bio&Zhonglian And the first appearance promotion of the international "Goose Selection APP".
Han Zhihui, President of Guanghua Bosite, and his working group came to Huaxin Bio to visit and exchange
2021-03-03
On the morning of March 2, Han Zhihui, President of Guanghua BST, together with the expert group Zhu Yanhui and Yu Runjie, visited Yantai Huaxin Bio-Pharmaceutical Technology Co., Ltd., and Li Lelin, Chairman of Huaxin Bio-Pharmaceutical, warmly received with the company’s high-level executives. Mr. Han Zhihui One party introduced the company's development history and vision in detail.
Chairman of Chifeng Wanze Pharmaceutical Company visited Huaxin Biology for investigation and cooperation
2021-06-18
On the morning of February 25th, Wang Yuan, chairman of "Chifeng Wanze Pharmaceutical Co., Ltd." and his party visited our company. The chairman of Huaxin Biotechnology Li Lelin and the company's senior leaders warmly approached and expressed his appreciation to the arrival of Chairman Wang Yuan and his party. A warm welcome.
"Miss Taohui" 100 echelon elites come to Huaxin to select domestic products!
2020-12-09
Following the "Miss Taohui" announcement on November 22nd, Chairman Youming led the company's high-level officials to visit Huaxin Biopharmaceuticals, and recognized the high standards, high quality, and high-tech products of Huaxin Biopharmaceuticals. On December 8th, Chairman Jie took charge again! Lead a hundred echelon elites to come to Huaxin to select good products, seek cooperation and seek development!
Our company participated in the Boao Forum for Asia Global Health Expo
2019-06-19
On June 10-12, the first Boao Forum for Asia Global Health Forum was held in China Railway Qingdao World Expo City, West Coast New District, Qingdao City, Shandong Province.
Our company was approved by Yantai City
2019-04-17
Recently, the Yantai Municipal Science and Technology Bureau announced the proposed project of the Yantai Key Research and Development Plan in 2019. The project "Research on the Effective Material Basis and Mechanism of the Classic Chinese Medicine Gentiana against Rheumatoid Arthritis" jointly declared by Yantai University and our company was approved. As a key research and development plan, the project number is "2019XDHZ109". The project is led by Yantai University.